Topic Highlight
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2011; 17(1): 42-48
Published online Jan 7, 2011. doi: 10.3748/wjg.v17.i1.42
Table 2 Indications for the use of contrast agents during endoscopic ultrasonography
StudyIndicationAgent used
Hocke et al[6]Differentiating benign from malignant lymph nodesSonoVue
Kanamori et al[22]Levovist
Nomura et al[8]Assessment of depth of invasion of esophageal cancerAir-filled Albumin
Nomura et al[8]Assessment of depth of invasion of gastric cancerAir-filled Albumin
Itoh et al[28]Differentiating benign from malignant intraductal papillary mucinous tumors of the pancreasLevovist
Hirooka et al[5]Gallbladder diseasesAlbunex
Ueno et al[34]Diagnosing Islet cell tumorsLevovist
Sakamoto et al[40]Determining origin of solid pancreatic massesLevovist with suspension of monosaccharide microparticles
Hirooka et al[24]Albunex
Dietrich et al[2]Levovist
Sofuni et al[41]Levovist
Becker et al[33]Discriminating between mass forming pancreatitis and pancreatic cancerOptison
Hocke et al[6]SonoVue
D’Onofrio et al[31]SonoVue
Hyodo et al[26]Diagnosing cause of chronic pancreatitis/mass forming pancreatitis (autoimmune pancreatitis)Levovist
D’Onofrio et al[31]SonoVue
Zhu et al[30]SonoVue
Kasono et al[7]Localizing small insulinomasLevovist